|
|
Blood, 1 November 2005, Vol. 106, No. 9, pp. 3020-3027.
Prepublished online as a Blood First Edition Paper on July 21, 2005; DOI 10.1182/blood-2004-01-0272.
Previous Article | Table of Contents | Next Article 
HEMATOPOIESIS
G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow
Craig L. Semerad,
Matthew J. Christopher,
Fulu Liu,
Brenton Short,
Paul J. Simmons,
Ingrid Winkler,
Jean-Pierre Levesque,
Jean Chappel,
F. Patrick Ross, and
Daniel C. Link
From the Division of Oncology, Department of Internal Medicine and Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO; Stem Cell Biology Laboratory, Peter MacCallum Cancer Institute, East Melbourne, Victoria, Australia; and Cancer Biotherapy Laboratory, Haematopoietic Stem Cell Team, Mater Medical Research Institute, South Brisbane, Queensland, Australia.
Accumulating evidence indicates that interaction of stromal cell-derived factor 1 (SDF-1/CXCL12 [CXC motif, ligand 12]) with its cognate receptor, CXCR4 (CXC motif, receptor 4), generates signals that regulate hematopoietic progenitor cell (HPC) trafficking in the bone marrow. During granulocyte colony-stimulating factor (G-CSF)induced HPC mobilization, CXCL12 protein expression in the bone marrow decreases. Herein, we show that in a series of transgenic mice carrying targeted mutations of their G-CSF receptor and displaying markedly different G-CSFinduced HPC mobilization responses, the decrease in bone marrow CXCL12 protein expression closely correlates with the degree of HPC mobilization. G-CSF treatment induced a decrease in bone marrow CXCL12 mRNA that closely mirrored the fall in CXCL12 protein. Cell sorting experiments showed that osteoblasts and to a lesser degree endothelial cells are the major sources of CXCL12 production in the bone marrow. Interestingly, osteoblast activity, as measured by histomorphometry and osteocalcin expression, is strongly down-regulated during G-CSF treatment. However, the G-CSF receptor is not expressed on osteoblasts; accordingly, G-CSF had no direct effect on osteoblast function. Collectively, these data suggest a model in which G-CSF, through an indirect mechanism, potently inhibits osteoblast activity resulting in decreased CXCL12 expression in the bone marrow. The consequent attenuation of CXCR4 signaling ultimately leads to HPC mobilization.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. J. Christopher, F. Liu, M. J. Hilton, F. Long, and D. C. Link
Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization
Blood,
August 13, 2009;
114(7):
1331 - 1339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Nervi, P. Ramirez, M. P. Rettig, G. L. Uy, M. S. Holt, J. K. Ritchey, J. L. Prior, D. Piwnica-Worms, G. Bridger, T. J. Ley, et al.
Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100
Blood,
June 11, 2009;
113(24):
6206 - 6214.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Eash, J. M. Means, D. W. White, and D. C. Link
CXCR4 is a key regulator of neutrophil release from the bone marrow under basal and stress granulopoiesis conditions
Blood,
May 7, 2009;
113(19):
4711 - 4719.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Schroeder, M. P. Rettig, P. Ramirez, and J. F. DiPersio
Optimal Mobilization of Normal and Leukemic Stem Cells via Modulation of Chemokine and Integrin Axes
Am. Assoc. Cancer Res. Educ. Book,
April 18, 2009;
2009(1):
15 - 22.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Hazen, M. J. Smith, C. Desponts, O. Winter, K. Moser, and W. G. Kerr
SHIP is required for a functional hematopoietic stem cell niche
Blood,
March 26, 2009;
113(13):
2924 - 2933.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Liongue, C. J. Hall, B. A. O'Connell, P. Crosier, and A. C. Ward
Zebrafish granulocyte colony-stimulating factor receptor signaling promotes myelopoiesis and myeloid cell migration
Blood,
March 12, 2009;
113(11):
2535 - 2546.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Y. Wu, L. E. Purton, S. J. Rodda, M. Chen, L. S. Weinstein, A. P. McMahon, D. T. Scadden, and H. M. Kronenberg
Osteoblastic regulation of B lymphopoiesis is mediated by Gs{alpha}-dependent signaling pathways
PNAS,
November 4, 2008;
105(44):
16976 - 16981.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Aicher, O. Kollet, C. Heeschen, S. Liebner, C. Urbich, C. Ihling, A. Orlandi, T. Lapidot, A. M. Zeiher, and S. Dimmeler
The Wnt Antagonist Dickkopf-1 Mobilizes Vasculogenic Progenitor Cells via Activation of the Bone Marrow Endosteal Stem Cell Niche
Circ. Res.,
October 10, 2008;
103(8):
796 - 803.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Devine, R. Vij, M. Rettig, L. Todt, K. McGlauchlen, N. Fisher, H. Devine, D. C. Link, G. Calandra, G. Bridger, et al.
Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction
Blood,
August 15, 2008;
112(4):
990 - 998.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Focosi, R. E. Kast, S. Galimberti, and M. Petrini
Conditioning response to granulocyte colony-stimulating factor via the dipeptidyl peptidase IV-adenosine deaminase complex
J. Leukoc. Biol.,
August 1, 2008;
84(2):
331 - 337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Mayack and A. J. Wagers
Osteolineage niche cells initiate hematopoietic stem cell mobilization
Blood,
August 1, 2008;
112(3):
519 - 531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Walkley, R. Qudsi, V. G. Sankaran, J. A. Perry, M. Gostissa, S. I. Roth, S. J. Rodda, E. Snay, P. Dunning, F. H. Fahey, et al.
Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease
Genes & Dev.,
June 15, 2008;
22(12):
1662 - 1676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Papayannopoulou and D. T. Scadden
Stem-cell ecology and stem cells in motion
Blood,
April 15, 2008;
111(8):
3923 - 3930.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Hermsen, F. E. Gomez, Y. Maeshima, Y. Sano, W. Kang, and K. A. Kudsk
Decreased Enteral Stimulation Alters Mucosal Immune Chemokines
JPEN J Parenter Enteral Nutr,
January 1, 2008;
32(1):
36 - 44.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Wengner, S. C. Pitchford, R. C. Furze, and S. M. Rankin
The coordinated action of G-CSF and ELR + CXC chemokines in neutrophil mobilization during acute inflammation
Blood,
January 1, 2008;
111(1):
42 - 49.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. De La Luz Sierra, P. Gasperini, P. J. McCormick, J. Zhu, and G. Tosato
Transcription factor Gfi-1 induced by G-CSF is a negative regulator of CXCR4 in myeloid cells
Blood,
October 1, 2007;
110(7):
2276 - 2285.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Hirbe, J. Rubin, O. Uluckan, E. A. Morgan, M. C. Eagleton, J. L. Prior, D. Piwnica-Worms, and K. N. Weilbaecher
Disruption of CXCR4 enhances osteoclastogenesis and tumor growth in bone
PNAS,
August 28, 2007;
104(35):
14062 - 14067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Hirbe, O. Uluckan, E. A. Morgan, M. C. Eagleton, J. L. Prior, D. Piwnica-Worms, K. Trinkaus, A. Apicelli, and K. Weilbaecher
Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner
Blood,
April 15, 2007;
109(8):
3424 - 3431.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Nakayama, N. Mutsuga, and G. Tosato
FGF2 posttranscriptionally down-regulates expression of SDF1 in bone marrow stromal cells through FGFR1 IIIc
Blood,
February 15, 2007;
109(4):
1363 - 1372.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Xing, M. A. Ryan, D. Daria, K. J. Nattamai, G. Van Zant, L. Wang, Y. Zheng, and H. Geiger
Increased hematopoietic stem cell mobilization in aged mice
Blood,
October 1, 2006;
108(7):
2190 - 2197.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. K. Kim, M. De La Luz Sierra, C. K. Williams, A. V. Gulino, and G. Tosato
G-CSF down-regulation of CXCR4 expression identified as a mechanism for mobilization of myeloid cells
Blood,
August 1, 2006;
108(3):
812 - 820.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|